Progressive multiple sclerosis: from pathogenic mechanisms to treatment

J Correale, MI Gaitán, MC Ysrraelit, MP Fiol - Brain, 2017 - academic.oup.com
During the past decades, better understanding of relapsing-remitting multiple sclerosis
disease mechanisms have led to the development of several disease-modifying therapies …

Multiple sclerosis animal models: a clinical and histopathological perspective

M Kipp, S Nyamoya, T Hochstrasser, S Amor - Brain pathology, 2017 - Wiley Online Library
There is a broad consensus that multiple sclerosis (MS) represents more than an
inflammatory disease: it harbors several characteristic aspects of a classical …

Natalizumab plus interferon beta-1a for relapsing multiple sclerosis

RA Rudick, WH Stuart, PA Calabresi… - … England Journal of …, 2006 - Mass Medical Soc
Background Interferon beta is used to modify the course of relapsing multiple sclerosis.
Despite interferon beta therapy, many patients have relapses. Natalizumab, an α4 integrin …

Multiple sclerosis normal‐appearing white matter: Pathology–imaging correlations

NM Moll, AM Rietsch, S Thomas… - Annals of …, 2011 - Wiley Online Library
Objective: The study was undertaken to determine the pathologic basis of subtle
abnormalities in magnetization transfer ratio (MTR) and diffusion tensor imaging (DTI) …

Optical coherence tomography: a window into the mechanisms of multiple sclerosis

EM Frohman, JG Fujimoto, TC Frohman… - Nature clinical practice …, 2008 - nature.com
The pathophysiology of multiple sclerosis (MS) is characterized by demyelination, which
culminates in a reduction in axonal transmission. Axonal and neuronal degeneration seem …

[HTML][HTML] Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration

KM Galetta, PA Calabresi, EM Frohman, LJ Balcer - Neurotherapeutics, 2011 - Elsevier
Axonal and neuronal degeneration are important features of multiple sclerosis (MS) and
other neurologic disorders that affect the anterior visual pathway. Optical coherence …

Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS

L Kappos, A Traboulsee, C Constantinescu… - Neurology, 2006 - neurology.org
Objective: To conduct systematic long-term follow-up (LTFU) of patients in the Prevention of
Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis …

MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system

M Filippi, MA Rocca - Journal of neurology, 2005 - Springer
The classical view of MS as a chronic inflammatory demyelinating disease leading to the
formation of focal central nervous system (CNS) white matter (WM) lesions has been …

Evaluation of the sensitivity of inhomogeneous magnetization transfer (ihMT) MRI for multiple sclerosis

E Van Obberghen, S Mchinda, A Le Troter… - American Journal of …, 2018 - ajnr.org
BACKGROUND AND PURPOSE: Inhomogeneous magnetization transfer is a new
endogenous MR imaging contrast mechanism that has demonstrated high specificity for …

Quantitative magnetization transfer imaging in relapsing-remitting multiple sclerosis: A systematic review and meta-analysis

EN York, MJ Thrippleton, R Meijboom… - Brain …, 2022 - academic.oup.com
Myelin-sensitive MRI such as magnetization transfer imaging has been widely used in
multiple sclerosis. The influence of methodology and differences in disease subtype on …